S230: HUMAN ΒETA-DEFENSIN 2 TREATMENT MODULATES THE INTESTINAL MICROBIOME AND THE ALLOGENEIC T CELL RESPONSE TO LIMIT ACUTE GRAFT-VERSUS-HOST DISEASE. (23rd June 2022) - Rückert, T.; Andrieux, G.; Boerries, M.; Woessner, N. M.; Minguet, S.; Doetsch, S.; Aumann, K.; Schiff, M; Braun, L. M.; Haring, E.; Siranosian, B. A.; Bhatt, A. S.; et al.